NASDAQ: ATEC
Alphatec Holdings Inc Stock

$10.93-0.59 (-5.12%)
Updated Mar 27, 2026
ATEC Price
$10.93
Fair Value Price
$23.38
Market Cap
$1.65B
52 Week Low
$8.81
52 Week High
$23.29
P/E
-11.39x
P/B
133.13x
P/S
4.13x
PEG
N/A
Dividend Yield
N/A
Revenue
$764.16M
Earnings
-$143.36M
Gross Margin
69.6%
Operating Margin
-12.76%
Profit Margin
-18.8%
Debt to Equity
62.67
Operating Cash Flow
$45M
Beta
1.24
Next Earnings
Apr 30, 2026
Ex-Dividend
N/A
Next Dividend
N/A

ATEC Overview

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine ATEC's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Device

Industry Rating
C
ATEC
Ranked
#18 of 99

Top Ranked Stocks in Industry

View Top Medical Device Stocks

Be the first to know about important ATEC news, forecast changes, insider trades & much more!

ATEC News

Overview

Due Diligence Score

Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ATEC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ATEC ($10.93) is undervalued by 53.26% relative to our estimate of its Fair Value price of $23.38 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ATEC ($10.93) is significantly undervalued by 53.26% relative to our estimate of its Fair Value price of $23.38 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
ATEC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ATEC due diligence checks available for Premium users.

Valuation

ATEC fair value

Fair Value of ATEC stock based on Discounted Cash Flow (DCF)

Price
$10.93
Fair Value
$23.38
Undervalued by
53.26%
ATEC ($10.93) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ATEC ($10.93) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ATEC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ATEC price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-11.39x
Industry
24.92x
Market
30.7x

ATEC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
133.13x
Industry
3.3x
ATEC is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ATEC's financial health

Profit margin

Revenue
$212.9M
Net Income
-$21.7M
Profit Margin
-10.2%
ATEC's Earnings (EBIT) of -$97.48M... subscribe to Premium to read more.
Interest Coverage Financials
ATEC's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$791.2M
Liabilities
$778.8M
Debt to equity
62.67
ATEC's short-term assets ($450.88M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ATEC's long-term liabilities ($559.61M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ATEC's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ATEC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$20.7M
Investing
-$15.7M
Financing
$206.0k
ATEC's operating cash flow ($45.23M)... subscribe to Premium to read more.
Debt Coverage Financials

ATEC vs Medical Device Stocks

TickerZen RatingMarket Cap1d %P/EP/B
ATECB$1.65B-5.12%-11.39x133.13x
AXGNB$1.62B-3.01%-92.00x12.60x
ESTAC$1.62B-7.68%-32.16x68.87x
AORTC$1.69B-3.02%160.41x3.77x
AHCOC$1.52B-1.84%-21.54x1.00x

Alphatec Holdings Stock FAQ

What is Alphatec Holdings's quote symbol?

(NASDAQ: ATEC) Alphatec Holdings trades on the NASDAQ under the ticker symbol ATEC. Alphatec Holdings stock quotes can also be displayed as NASDAQ: ATEC.

If you're new to stock investing, here's how to buy Alphatec Holdings stock.

What is the 52 week high and low for Alphatec Holdings (NASDAQ: ATEC)?

(NASDAQ: ATEC) Alphatec Holdings's 52-week high was $23.29, and its 52-week low was $8.81. It is currently -53.07% from its 52-week high and 24.06% from its 52-week low.

How much is Alphatec Holdings stock worth today?

(NASDAQ: ATEC) Alphatec Holdings currently has 151,356,620 outstanding shares. With Alphatec Holdings stock trading at $10.93 per share, the total value of Alphatec Holdings stock (market capitalization) is $1.65B.

Alphatec Holdings stock was originally listed at a price of $102.00 in Jun 12, 2006. If you had invested in Alphatec Holdings stock at $102.00, your return over the last 19 years would have been -89.28%, for an annualized return of -11.09% (not including any dividends or dividend reinvestments).

How much is Alphatec Holdings's stock price per share?

(NASDAQ: ATEC) Alphatec Holdings stock price per share is $10.93 today (as of Mar 27, 2026).

What is Alphatec Holdings's Market Cap?

(NASDAQ: ATEC) Alphatec Holdings's market cap is $1.65B, as of Mar 31, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Alphatec Holdings's market cap is calculated by multiplying ATEC's current stock price of $10.93 by ATEC's total outstanding shares of 151,356,620.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.